64
Participants
Start Date
March 21, 2021
Primary Completion Date
July 1, 2021
Study Completion Date
October 19, 2021
LT3001 drug product
Multiple doses of LT3001 drug product administered by intravenous infusion
Placebo
Multiple doses of Placebo administered by intravenous infusion
Aspirin
Loading and maintenance doses of Aspirin administered by oral
Clopidogrel
Loading and maintenance doses of Clopidogrel administered by oral
Apixaban
Multiple doses of Apixaban administered by oral
Dabigatran
Multiple doses of Dabigatran administered by oral
RECRUITING
Lumosa Phase 1 Unit, Cypress
Lead Sponsor
Lumosa Therapeutics Co., Ltd.
INDUSTRY